Daily News: Baxter Heparin Use Suspended at Hospital
-Nurse.com
05/09/2009 - At least five adverse patient outcomes suspected to be associated with the use of pre-mixed bags of heparin from Baxter International Inc., prompted Beebe Medical Center, Lewes, Del., to suspend use of the products. One patient was transferred by air ambulance to Christiana Care Health System and two patients to the University of Maryland Hospital. Additional patients are being closely monitored on-site at Beebe, according to a news release from the hospital.
Last year, Baxter recalled heparin sodium injection multi-dose, single-dose vials, and Hep-Lock heparin flush products after reports of adverse reactions, including 19 deaths. They were primarily allergic or hypersensitivity-type reactions to a contaminant. Patients may have had oral swelling, nausea, vomiting, sweating, shortness of breath, and severe hypotension. Symptoms usually developed within minutes of heparin administration, but for some individuals they were delayed.
Heathcare workers should report adverse events to the U.S. Food and Drug Administration’s MedWatch hotline at 800-FDA-1088 or download a form at www.fda.gov/medwatch/getforms.htm.
If you or a loved one have experienced Heparin Sodium Injection side effects you may be entitled to compensation. Contact the Heparin attorneys of Ennis & Ennis today for a free confidential case evaluation. Our on staff nurse and lawyers are standing by to answer any questions you may have regarding Heparin side effects, a possible Heparin class action lawsuit, or any other type of Heparin Sodium Injection litigation.
|